Benign recurrent intrahepatic cholestasis: review and long-term follow-up of five cases
Authors:
- 10 January 2012
- journal article
- case report
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 47 (4) , 482-488
Abstract
Objective. Benign recurrent intrahepatic cholestasis (BRIC) is a rare autosomal recessive inherited disorder characterized by intermittent episodes of cholestatic jaundice. For the patients, the disease is a physical and psychological challenge. There is no curable treatment, but symptomatic relief is described following treatment with rifampicin or plasmapheresis. Material and methods. Five patients suffering from BRIC followed up for 17 years by one consultant are described. Two patients were treated with rifampicin and plasmapheresis, two with rifampicin alone, and one with plasmapheresis. Results. The treatments showed symptomatic relief, effect on biochemical parameters, and earlier clinical remission compared with no treatment or treatment with other substances like cholestyramine, antihistamines, and ursodeoxycholic acid. Conclusions. Both rifampicin and plasmapheresis represent important therapeutic options of acute cholestatic attacks in patients with BRIC. As a noninvasive treatment, rifampicin may be the first choice.Keywords
This publication has 14 references indexed in Scilit:
- Familial cholestasis: Progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancyBest Practice & Research Clinical Gastroenterology, 2010
- Hepatocanalicular Transport Defects: Pathophysiologic Mechanisms of Rare DiseasesGastroenterology, 2006
- Inborn Errors of Biliary Canalicular Transport Systems2005
- Characterization of mutations in ATP8B1 associated with hereditary cholestasisHepatology, 2004
- A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasisNature Genetics, 1998
- Genome screening by searching for shared segments: mapping a gene for benign recurrent intrahepatic cholestasisNature Genetics, 1994
- Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: A study of bile acid metabolismHepatology, 1991
- Treatment of Patients With Benign Recurrent Intrahepatic CholestasisHepatology, 1989
- INTERMITTENT INTRAHEPATIC CHOLESTASIS OF UNKNOWN ETIOLOGY IN FIVE YOUNG MALES FROM THE FAROE ISLANDS1Acta Medica Scandinavica, 1969
- BENIGN RECURRENT INTRAHEPATIC " OBSTRUCTIVE " JAUNDICEThe Lancet, 1959